An explorative study of the views and experiences of food and weight loss in patients with operable pancreatic cancer perioperatively and following surgical intervention

Cooper, Christine; Burden, Sorrel; Molassiotis, Alex

doi:10.1007/s00520-014-2455-1

Cited by 23 publications

(36 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lack of nutritional treatment not only impacts on clinical outcomes and prognosis but it also causes significant distress for patients69 and their family members and carers 70…”

Section: Discussionmentioning

confidence: 99%

“…18 Although treatment of cancer-related malnutrition is often treated with a degree of nihilism; early, targeted, multimodal nutritional treatment is essential and yields tangible clinical benefits. 67,68 Lack of nutritional treatment not only impacts on clinical outcomes and prognosis but it also causes significant distress for patients 69 and their family members and carers. 70 Although CT assessment is the gold standard method of body composition analysis in oncology patients, widespread application in the clinical setting is not feasible because of resource and staffing constraints.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?

Bhuachalla

Daly

Power

et al. 2017

J cachexia sarcopenia muscle

View full text Add to dashboard Cite

BackgroundNutrition screening on admission to hospital is mandated in many countries, but to date, there is no consensus on which tool is optimal in the oncology setting. Wasting conditions such as cancer cachexia (CC) and sarcopenia are common in cancer patients and negatively impact on outcomes; however, they are often masked by excessive adiposity. This study aimed to inform the application of screening in cancer populations by investigating whether commonly used nutritional screening tools are adequately capturing nutritionally vulnerable patients, including those with abnormal body composition phenotypes (CC, sarcopenia, and myosteatosis).MethodsA prospective study of ambulatory oncology outpatients presenting for chemotherapy was performed. A detailed survey incorporating clinical, nutritional, biochemical, and quality of life data was administered. Participants were screened for malnutrition using the Malnutrition Universal Screening Tool (MUST), Malnutrition Screening Tool (MST), and the Nutritional Risk Index (NRI). Computed tomography (CT) assessment of body composition was performed to diagnose CC, sarcopenia, and myosteatosis according to consensus criteria.ResultsA total of 725 patients (60% male, median age 64 years) with solid tumours participated (45% metastatic disease). The majority were overweight/obese (57%). However, 67% were losing weight, and CT analysis revealed CC in 42%, sarcopenia in 41%, and myosteatosis in 46%. Among patients with CT‐identified CC, the MUST, MST, and NRI tools categorized 27%, 35%, and 7% of them as ‘low nutritional risk’, respectively. The percentage of patients with CT‐identified sarcopenia and myosteatosis that were categorised as ‘low nutritional risk’ by MUST, MST and NRI were 55%, 61%, and 14% and 52%, 50%, and 11%, respectively. Among these tools, the NRI was most sensitive, with scores <97.5 detecting 85.8%, 88.6%, and 92.9% of sarcopenia, myosteatosis, and CC cases, respectively. Using multivariate Cox proportional hazards models, NRI score < 97.5 predicted greater mortality risk (hazard ratio 1.8, confidence interval: 1.2–2.8, P = 0.007).ConclusionsHigh numbers of nutritionally vulnerable patients, with demonstrated abnormal body composition phenotypes on CT analysis, were misclassified by MUST and MST. Caution should be exercised when categorizing the nutritional risk of oncology patients using these tools. NRI detected the majority of abnormal body composition phenotypes and independently predicted survival. Of the tools examined, the NRI yielded the most valuable information from screening and demonstrated usefulness as an initial nutritional risk grading system in ambulatory oncology patients.

show abstract

“…Lack of nutritional treatment not only impacts on clinical outcomes and prognosis but it also causes significant distress for patients69 and their family members and carers 70…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?

Bhuachalla

Daly

Power

et al. 2017

J cachexia sarcopenia muscle

View full text Add to dashboard Cite

show abstract

“…Lack of information on food choice, nutritional counselling and dialogue with nurses has previously shown to negatively affect patients' experiences (Cooper, 2014;Holst, Rasmussen, & Laursen, 2011;Johns et al, 2010). Thus, it is important to include the perspectives of patients with amputation to determine how best to deliver nutritional care to this group.…”

Section: Rationale and Aimmentioning

confidence: 99%

“…Provision of tailored nutritional care following lower extremity amputation requires an understanding of patient's views on their choice of food, dietary advice and the role of nutrition in their admission. Lack of information on food choice, nutritional counselling and dialogue with nurses has previously shown to negatively affect patients’ experiences (Cooper, ; Holst, Rasmussen, & Laursen, ; Johns et al., ). Thus, it is important to include the perspectives of patients with amputation to determine how best to deliver nutritional care to this group.…”

Section: Introductionmentioning

confidence: 99%

Perceptions and experiences of nutritional care following the overwhelming experience of lower extremity amputation: A qualitative study

Jensen

Green

Petersen

et al. 2018

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…5 For patients with pancreatic cancer, existing evidence suggests that post-operatively, patients receive insufficient information from their health care providers to self-manage their condition at home. 6 For this group of patients, surgery remains the only established curative treatment. A common surgical procedure for tumour resection is the pylorus-preserving pancreaticoduodenectomy (PPPD).…”

Section: Introductionmentioning

confidence: 99%

Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management

Dunleavy

Al-Mukhtar

Halliday

2018

Clinical Nutrition ESPEN

View full text Add to dashboard Cite

Enabling patients to appropriately self-manage PERT may lessen the post-treatment burden. Our findings suggest that support should continue throughout the recovery phase and should address the patient's 'self-management journey'. Intervention by healthcare professionals, such as a specialist dietitian is likely to be beneficial. Furthermore there are focal issues, primarily explicit education and appropriately timed information that require consideration by those developing and delivering services.

show abstract

An explorative study of the views and experiences of food and weight loss in patients with operable pancreatic cancer perioperatively and following surgical intervention

Cited by 23 publications

References 31 publications

Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?

Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?

Perceptions and experiences of nutritional care following the overwhelming experience of lower extremity amputation: A qualitative study

Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management

Contact Info

Product

Resources

About